Brian Mckeon Purchases 10,000 Shares of DENTSPLY SIRONA (NASDAQ:XRAY) Stock

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Director Brian Mckeon bought 10,000 shares of the business’s stock in a transaction dated Friday, June 12th. The shares were purchased at an average price of $10.12 per share, for a total transaction of $101,200.00. Following the transaction, the director directly owned 10,000 shares of the company’s stock, valued at approximately $101,200. This represents a ∞ increase in their position. The purchase was disclosed in a filing with the SEC, which is available through this hyperlink.

DENTSPLY SIRONA Stock Performance

Shares of XRAY stock opened at $10.45 on Wednesday. The stock has a market capitalization of $2.09 billion, a PE ratio of -3.32, a price-to-earnings-growth ratio of 1.21 and a beta of 0.89. DENTSPLY SIRONA Inc. has a 52-week low of $9.40 and a 52-week high of $17.09. The stock’s 50-day moving average price is $10.93 and its 200 day moving average price is $11.70. The company has a quick ratio of 0.98, a current ratio of 1.53 and a debt-to-equity ratio of 1.52.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its quarterly earnings results on Tuesday, May 5th. The medical instruments supplier reported $0.27 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.28 by ($0.01). The company had revenue of $880.00 million during the quarter, compared to analyst estimates of $841.80 million. DENTSPLY SIRONA had a negative net margin of 17.06% and a positive return on equity of 18.83%. The business’s revenue was up .1% on a year-over-year basis. During the same quarter last year, the firm earned $0.43 EPS. DENTSPLY SIRONA has set its FY 2026 guidance at 1.400-1.500 EPS. As a group, equities research analysts forecast that DENTSPLY SIRONA Inc. will post 1.42 EPS for the current year.

Institutional Investors Weigh In On DENTSPLY SIRONA

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Bank of America Corp DE lifted its stake in DENTSPLY SIRONA by 18.3% in the 1st quarter. Bank of America Corp DE now owns 2,432,457 shares of the medical instruments supplier’s stock valued at $28,217,000 after buying an additional 375,994 shares in the last quarter. RBF Capital LLC lifted its stake in DENTSPLY SIRONA by 2.5% in the 1st quarter. RBF Capital LLC now owns 205,000 shares of the medical instruments supplier’s stock valued at $2,378,000 after buying an additional 5,000 shares in the last quarter. Arkadios Wealth Advisors purchased a new stake in DENTSPLY SIRONA in the 1st quarter valued at approximately $870,000. California State Teachers Retirement System lifted its stake in DENTSPLY SIRONA by 24.0% in the 1st quarter. California State Teachers Retirement System now owns 232,031 shares of the medical instruments supplier’s stock valued at $2,692,000 after buying an additional 44,918 shares in the last quarter. Finally, Royal Bank of Canada lifted its stake in DENTSPLY SIRONA by 137.7% in the 1st quarter. Royal Bank of Canada now owns 256,701 shares of the medical instruments supplier’s stock valued at $2,978,000 after buying an additional 148,702 shares in the last quarter. Hedge funds and other institutional investors own 95.70% of the company’s stock.

Analysts Set New Price Targets

Several brokerages recently issued reports on XRAY. Mizuho dropped their price target on DENTSPLY SIRONA from $16.00 to $14.00 and set a “neutral” rating on the stock in a research report on Wednesday, May 6th. Citigroup began coverage on DENTSPLY SIRONA in a research report on Wednesday, April 15th. They issued a “sell” rating and a $10.00 price target on the stock. Barrington Research boosted their price target on DENTSPLY SIRONA from $14.00 to $17.00 and gave the company an “outperform” rating in a research report on Monday, March 2nd. Wells Fargo & Company boosted their price target on DENTSPLY SIRONA from $12.00 to $13.00 and gave the company an “equal weight” rating in a research report on Friday, February 27th. Finally, Zacks Research upgraded DENTSPLY SIRONA from a “strong sell” rating to a “hold” rating in a research report on Monday, March 2nd. Three equities research analysts have rated the stock with a Buy rating, eight have given a Hold rating and three have given a Sell rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $13.55.

About DENTSPLY SIRONA

Dentsply Sirona Inc (NASDAQ: XRAY) is a leading global manufacturer of professional dental products and technologies. The company, formed through the merger of Dentsply International and Sirona Dental Systems in February 2016, brings together a long heritage of innovation in dental care. Headquartered in Charlotte, North Carolina, Dentsply Sirona develops and markets a comprehensive range of dental consumables, laboratory products, and advanced imaging and CAD/CAM systems.

The company’s product portfolio spans preventive, restorative, orthodontic, endodontic and surgical care.